On September 2, 2021 Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, reported that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate in three upcoming virtual investor conferences (Press release, Harpoon Therapeutics, SEP 2, 2021, View Source [SID1234587191]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A panel discussion ("Large Molecule Drugs for Oncology – Framing the Tip of the Spear for Novel Antibodies and Protein Therapeutics") at Citi’s 16th Annual BioPharma Conference on Thursday, September 9, 2021 at 1:25 p.m. ET / 10:25 a.m. PT;

A fireside chat at Baird’s 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 3:10 p.m. ET / 12:10 p.m. PT; and

A fireside chat at Cantor’s 2021 Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 2 p.m. ET / 11 a.m. PT.
Live webcasts from the Citi and Cantor conference events will be available from the Events and Presentations section of the company’s website at View Source and will be archived there shortly after the events.